Diabetes prescriptions may be more stable and predictable, while obesity-related prescriptions can involve more frequent dose adjustments, therapy initiation, and discontinuation
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors should be considered for all patients with type 2 diabetes requiring glycaemic control or to further reduce proteinuria after ACE inhibitor or ARB therapy
"With the introduction of branded products such as the Wegovy pill and Wegovy pen, we are already seeing our addressable market expand significantly
Are GLP-1 patches safe to use
Recently, a 26week trial (ADJUST-T1D) randomized 72 type 1 diabetic patients with obesity to semaglutide or placebo
The Nomad Travel Cooling Cases are another standout slim, thermos-style cases that keep your medication refrigerated for up to 33 hours entirely without electricity